- Renovates Karapitiya Cancer Treatment Unit and NHSL Plastic Surgery Unit
- Donated over 380,000 bottles of activated carbon powder FOC to hospitals island-wide
- Over Rs. 13mn invested in supporting the healthcare sector
Highlighting the pivotal role of the healthcare sector in safeguarding public well-being and saving lives, Haycarb, a member of the Hayleys Group and a leading manufacturer of high-value coconut shell activated carbon, has successfully completed essential renovations at two leading national hospitals.
The exporter invested over Rs. 13 million in renovating the Plastic Surgery Unit at the National Hospital of Sri Lanka (NHSL) and the Cancer Treatment Unit at the Karapitya Teaching Hospital.
The recent renovations add to a 20-year donation drive of over 380,000 bottles of its patented Activated Carbon (RMPP1001) to treat victims of poison ingestions or drug-related overdoses, distributed to hospitals across the island.
“Sri Lanka’s healthcare sector has bravely survived and served through the nation’s most challenging times, consistently working towards protecting the people of Sri Lanka. Last year’s economic crisis strained the system, which was already grappling with the challenges of the Covid-19 pandemic.
“Over the past years, we have supported the public healthcare sector by providing our invaluable activated carbon for patients. Our 50th year celebrations are all about coming together to drive value and change lives, and so we wanted to extend our support further for the benefit of Sri Lankan society. I’m very proud of our team for their coordinated efforts, which are impacting patients’ outcomes and lives in significant and meaningful ways,” Haycarb Managing Director Rajitha Kariyawasan said.
Accordingly, Haycarb restored the only Plastic Surgery Unit in the country at the NHSL, which provides burn care and reconstructive surgery. Renovations to the unit, operating around the clock, were planned out in stages, allowing critical patients to be treated while the much-needed reconstruction of the entire facility took place.
The exporter refurbished the Day Surgery Unit, Physiotherapy Unit and Ward No.4 with partitions to improve patient privacy and hygiene, provided smart TVs connected to laptops to view X-rays and installed new air conditioning facilities. Haycarb also furnished the unit with new washbasins, medicine cabinets, as well as suction and sterilizing units under the initiative.
Similarly, the team also renovated the Cancer Treatment Unit at the Karapitiya Teaching Hospital, refurbishing the entire ward’s ventilation, washrooms and interior. Haycarb further repaired the communication system for the in-patient isolation room after radio/iodine therapy and constructed a separate area for garbage bins and trolley storage.
Proven to be an effective and affordable antidote that has saved thousands of lives in Sri Lanka, the activated carbon produced by Haycarb has become the primary treatment for victims of attempted suicide and other poisonings. The product has replaced the more expensive antidotes used in hospitals overseas.
Haycarb is a leading global pioneer in manufacturing high-value coconut shell activated carbon with manufacturing facilities in Sri Lanka, Thailand and Indonesia and supported by marketing offices in the USA, UK and Australia. The company produces various specialized activated carbon solutions for diverse applications, including water and air purification, medicine, battery technology, cosmetics gold recovery, and more.
(From left) Hayleys Group Chairman and Chief Executive, Mohan Pandithage, Hayleys Executive Director Sarath Ganegoda and NHSL Deputy Director General (CEO) Dr. Kumara Wickremasinghe commemorating the opening of the new ward at the NHSL.
(From left) Haycarb PLC Deputy Managing Director, Brahman Balaratnarajah, KTH Director Dr. S.D.U.M Ranga and Haycarb PLC Finance and IT Director, Jeevani Abeyratne opening the new wards at KTH
Before and after pictures of the NHSL Plastic Surgery Unit Day Procedure Ward